Royal Bank of Canada’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,637
| Closed | -$111K | – | 7990 |
|
|
2021
Q1 | $111K | Sell |
4,637
-25,870
| -85% | -$481K | ﹤0.01% | 5391 |
|
|
2020
Q4 | $445K | Buy |
30,507
+30,162
| +8,743% | +$400K | ﹤0.01% | 4236 |
|
|
2020
Q3 | $5K | Sell |
345
-114
| -25% | -$1.74K | ﹤0.01% | 6157 |
|
|
2020
Q2 | $7K | Buy |
459
+167
| +57% | +$1.7K | ﹤0.01% | 5971 |
|
|
2020
Q1 | $1K | Sell |
292
-1,418
| -83% | -$6.65K | ﹤0.01% | 6572 |
|
|
2019
Q4 | $8K | Buy |
1,710
+1,706
| +42,650% | +$9.41K | ﹤0.01% | 6237 |
|
|
2019
Q3 | $0 | Sell |
4
-373
| -99% | -$2.33K | ﹤0.01% | 7352 |
|
|
2019
Q2 | $2K | Buy |
377
+373
| +9,325% | +$2.63K | ﹤0.01% | 6638 |
|
|
2019
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 7254 |
|
|
2018
Q4 | $0 | Sell |
4
-1,037
| -100% | -$5.4K | ﹤0.01% | 7351 |
|
|
2018
Q3 | $8K | Buy |
1,041
+980
| +1,607% | +$7.19K | ﹤0.01% | 6098 |
|
|
2018
Q2 | $0 | Buy |
61
+57
| +1,425% | +$377 | ﹤0.01% | 6903 |
|
|
2018
Q1 | $0 | Sell |
4
-371
| -99% | -$1.84K | ﹤0.01% | 7007 |
|
|
2017
Q4 | $2K | Sell |
375
-3,908
| -91% | -$23.5K | ﹤0.01% | 6323 |
|
|
2017
Q3 | $41K | Buy |
4,283
+4,162
| +3,440% | +$43.2K | ﹤0.01% | 5541 |
|
|
2017
Q2 | $1K | Sell |
121
-1,364
| -92% | -$17.4K | ﹤0.01% | 6474 |
|
|
2017
Q1 | $19K | Sell |
1,485
-2,467
| -62% | -$29.7K | ﹤0.01% | 5663 |
|
|
2016
Q4 | $49K | Buy |
3,952
+2,588
| +190% | +$30.7K | ﹤0.01% | 5271 |
|
|
2016
Q3 | $16K | Buy |
1,364
+8
| +0.6% | +$77 | ﹤0.01% | 5632 |
|
|
2016
Q2 | $12K | Buy |
1,356
+80
| +6% | +$548 | ﹤0.01% | 5696 |
|
|
2016
Q1 | $7K | Sell |
1,276
-91
| -7% | -$507 | ﹤0.01% | 5854 |
|
|
2015
Q4 | $11K | Sell |
1,367
-1,680
| -55% | -$12.9K | ﹤0.01% | 5942 |
|
|
2015
Q3 | $24K | Sell |
3,047
-612
| -17% | -$5.66K | ﹤0.01% | 5496 |
|
|
2015
Q2 | $34K | Buy |
3,659
+2,383
| +187% | +$24K | ﹤0.01% | 5431 |
|
|
2015
Q1 | $17K | Hold |
1,276
| – | – | ﹤0.01% | 5412 |
|
|
2014
Q4 | $17K | Buy |
+1,276
| New | +$14.3K | ﹤0.01% | 5461 |
|
Royal Bank of Canada's GNMK Position: Q2 2021 in Review
Royal Bank of Canada sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 4,637 shares — an estimated $111K sold.
Royal Bank of Canada first reported a position in GNMK in Q4 2014 and held it in 26 quarters. The position peaked at $445K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Royal Bank of Canada reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Royal Bank of Canada sold 4,637 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $111K.
- Royal Bank of Canada first reported a position in GenMark Diagnostics, Inc in Q4 2014 and held it in 26 quarters.
- Royal Bank of Canada's GenMark Diagnostics, Inc position peaked at $445K in Q4 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Royal Bank of Canada's 13F filing for Q2 2021, filed 16 Aug 2021.